Multiply Labs

Summary

This business specializes in the development and manufacturing of robotic systems designed to produce precision medicines, particularly in the cell therapy sector. Their technology enables the industrial-scale production of gene-modified cell therapies, ensuring compatibility with leading GMP instruments. They offer a flexible approach, allowing clients to select module combinations tailored to their specific processes, and emphasize high-throughput capabilities through parallel module usage. Additionally, they provide digital quality control solutions that enhance process data management.